The Indian benchmark indices are set to open on a positive note after US Fed left key rates unchanged but signalled possible interest rate cuts later this year. On Wednesday, benchmark indices on ended flat on the back of selective buying and selling in equities. The BSE Sensex gained 66.40 points at 39,112.74 while the Nifty50 ended flat at 11,691.50.
NSE
Among stocks, Ashwani Gujral is bearish on Repco Home Finance, Raymond, and Amara Raja Batteries, while he is bullish on ICICI Prudential Life and Siemens India. Sudarshan Sukhani had a 'buy' call on Britannia Industries, Syndicate Bank, L&T and 'sell' call on India Cements and Sun Pharma. Whereas, Mitessh Thakkar is positive on Havells India and Kotak Bank, however, he is negative on Hindalco and Strides Pharma.
Here are the top buy-sell calls by market experts for Thursday:
Ashwani Gujral - ashwanigujral.com
- Sell Repco Home Finance with a stop loss of Rs 364, target at Rs 346
- Sell Amara Raja with a stop loss of Rs 590, target at Rs 565
- Sell Raymond with a stop loss of Rs 245, target at Rs 230
- Buy ICICI Prudential with a stop loss of Rs 360, target at Rs 375
- Buy Siemens India with a stop loss of Rs 1,255, target at Rs 1,300
Sudarshan Sukhani - s2analytics.com
- Buy Britannia Industries with a stop loss of Rs 2,845, target at Rs 2,940
- Buy Larsen & Toubro with a stop loss of Rs 1,465, target at Rs 1,550
- Buy Syndicate Bank with a stop loss of Rs 35, target at Rs 37.5
- Sell Sun Pharma with a stop loss of Rs 382, target at Rs 365
- Sell India Cements with a stop loss of Rs 93.5, target at Rs 90
Mitessh Thakkar - mitesshthakkar.com
- Sell Hindalco with a stop loss of Rs 196, target at Rs 183
- Sell Strides Pharma with a stop loss of Rs 403, target at Rs 380
- Buy Havells India with a stop loss of Rs 776, target at Rs 800
- Buy Kotak Mahindra Bank with a stop loss below Rs 1,485, target at Rs 1,522
Also, track all live market action on CNBC-TV18 Market Blog
Disclaimer: CNBCTV18.com advises users to check with certified experts before taking any investment decisions